Fulcrum Therapeutics, Inc. (FULC)

NASDAQ

$3.69

$-0.06

(-1.73%)

After-Hours

Fulcrum Therapeutics, Inc. (FULC) Live Price Chart

Last updated: ⁦2026-10-13 21:15:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Fulcrum Therapeutics, Inc. (FULC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.69, with a market capitalization of $287.96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.83 to $15.74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$287.96M
Open	$3.75
Day's High	$33.10
Day's Low	$2.25
Previous Close	$3.75
Volume	1.35M
Average Volume	1.55M
P/E Ratio	--
52-Week High	$15.74
52-Week Low	$2.83
Dividend Yield	--
Earnings Date	--

Fulcrum Therapeutics, Inc. (FULC) After-Hours Stock Price

Fulcrum Therapeutics, Inc. (FULC) is trading at $3.69 in after-hours trading as of 2026-10-13 19:59:51, down 1.73% ($0.06) from the regular-session close of $3.75.

After-hours trading shows how investors are pricing FULC after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Fulcrum Therapeutics, Inc. (FULC) 7-Day Stock Price Change

Over the past seven days, Fulcrum Therapeutics, Inc. (FULC) moved from $3.69 to $3.69, representing a decline of 0.14% ($0.00).

The stock traded between $3.65 and $3.79 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.

The average daily volume was 1.49 million shares, down versus the previous seven-day period, indicating lower trading activity.

FULC 52-Week Price Position

Position in Range: 6.6%

52W Low$2.83

52W High$15.74

FULC is currently trading at $3.69, placing it 6.6% of the way from its 52-week low of $2.83 to its 52-week high of $15.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Fulcrum Therapeutics, Inc. (FULC)?

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Fulcrum Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	55
Exchange	NASDAQ
Company Website	https://www.fulcrumtx.com

How to Buy Fulcrum Therapeutics, Inc. (FULC) Stock on MEXC

Eligible investors can buy real shares of Fulcrum Therapeutics, Inc. (FULC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for FULC and Place Your Order

Open the RealStocks trading page and search for FULC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Fulcrum Therapeutics, Inc. (FULC) stock price today?

Fulcrum Therapeutics, Inc. (FULC) is currently trading at $ 3.69, down 1.73% ($0.06) from the previous close of $ 3.75. Intraday prices update in real time during regular trading hours.

2.Is FULC stock going up or down today?

As of 2026-10-13 19:59:51, FULC is trading at $ 3.69, down 1.73% ($0.06) from its previous close of $ 3.75. The stock has traded between $ 2.25 and $ 33.10 during today’s regular session. Past price movements do not guarantee future results.

3.What is FULC pre-market price?

As of 2026-10-13 19:59:51, FULC is trading at $ 3.71 in pre-market trading, down 1.20% ($0.04) from the previous close of $ 3.75. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is FULC after-hours price?

As of 2026-10-13 19:59:51, FULC is trading at $ 3.69 in after-hours trading, down 1.73% ($0.06) from the regular-session close of $ 3.75. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is FULC stock trading now?

FULC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does FULC sit relative to its 52-week high and low?

Over the past 52 weeks, FULC has traded between a low of $ 2.83 and a high of $ 15.74. At $ 3.69, the stock is positioned 6.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Fulcrum Therapeutics, Inc. in?

Fulcrum Therapeutics, Inc. (FULC) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Fulcrum Therapeutics, Inc.'s market capitalization and where is it listed?

Fulcrum Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 287.96M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is FULC valued in terms of P/E ratio and EPS?

FULC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Fulcrum Therapeutics, Inc. pay a dividend?

Fulcrum Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.